Fig 1: XPO1 suppresses TNFSF15 expression by inhibiting IRF3-mediated transcriptional activation.a GSEA of transcriptional changes after XPO1 depletion in NCI-H1688 and NCI-H196 cells, showing overlapping dysfunctional Hallmark gene sets (left) and the 11 shared gene sets (right). b Differential expression of five commonly upregulated cytokine- and TNF-related genes in XPO1-silenced cells. c RT-qPCR and ELISA analysis of TNFSF15 expression and secretion. d ATAC-seq signal at regions with increased accessibility after XPO1 depletion, centered within ±3 kb of differential peaks. e ATAC-seq tracks at the TNFSF15 locus. f GO enrichment analysis of genes associated with increased promoter accessibility following XPO1 depletion. The top ten enriched terms are shown. g HOMER motif analysis of differentially accessible chromatin regions and the top five upregulated transcription factors in XPO1-silenced cells. h Predicted IRF3-binding sites in the TNFSF15 promoter and the corresponding mutant sequences. This schematic was created by the authors using Adobe Illustrator and contains no third-party material. i Dual-luciferase reporter assay in NCI-H1688 cells expressing IRF3 and reporter constructs containing the wild-type TNFSF15 promoter or promoter variants with mutations in the indicated predicted IRF3-binding sites. j ChIP-qPCR analysis of IRF3 occupancy at the TNFSF15 promoter. Representative images are shown. Data in (a) were calculated using a sign-specific permutation test based on permutation-generated enrichment-score null distributions; FDR q values were estimated within the GSEA framework. Data in (b) was analyzed using DESeq2; two-sided Wald-test P values were adjusted using the Benjamini–Hochberg method. Data in (c, i) were analyzed using two-sided unpaired Student’s t tests. Data in (f) was assessed with GO term enrichment analysis using a one-sided hypergeometric test with Benjamini–Hochberg correction. Data in (g) was analyzed using HOMER with GC- and length-matched background sequences. Data in (a, b) are from n = 3 biologically independent samples per group; Data in (c, i, j) are from n = 3 biologically independent experiments. ATAC-seq analyses in (d, g) are from n = 2 biologically independent samples per group. Data in (c, i) are presented as mean±s.d. Source data are provided as a Source Data file.
Fig 2: TRIM21 catalyses K48-linked polyubiquitylation of IRF3 at lysine 313.a Schematic representation of the domain structures of TRIM21 and IRF3 and the truncation mutants used to map their interaction (left). Immunoprecipitation and immunoblot analysis of lysates from HEK293T cells expressing the indicated deletion mutants (right). This schematic was created by the authors using Adobe Illustrator and contains no third-party material. b Deletion of the DNA-binding domain (DBD) of IRF3 impaired TRIM21-mediated polyubiquitylation of IRF3. c Modeled TRIM21-IRF3 complex highlighting interactions between IRF3 R31 and TRIM21 F449/D451. Putative polar interactions are indicated by yellow dashed lines. d Schematic representation of IRF3 and the indicated mutant constructs. This schematic was created by the authors using Adobe Illustrator and contains no third-party material. e Immunoprecipitation and immunoblot analysis of lysates from HEK293T cells expressing HA-TRIM21 together with MYC-IRF3 or MYC-IRF3-R31A. f RT-qPCR and ELISA analysis of TNFSF15 mRNA expression and secreted protein levels, respectively, in the indicated NCI-H1048 cells. g Ubiquitylation assay in TRIM21-knockdown NCI-H1688 cells reconstituted with wild-type (WT) or ligase-dead (LD) HA-tagged TRIM21. h IRF3 polyubiquitylation in HEK293T cells expressing wild-type ubiquitin, Ub-K48R or Ub-K63R. i K48-linked polyubiquitylation of IRF3 after XPO1 manipulation. j IRF3 polyubiquitylation after re-expression of wild-type or mutant IRF3 in TRIM21-depleted cells with or without TRIM21 rescue. Data in (f) was analyzed using two-sided unpaired t-tests. Data in (a, b) and (e–j) are representative of n = 3 biologically independent experiments. Data are presented as mean ± s.d. Source data are provided as a Source Data file.
Fig 3: Schematic illustration of the proposed mechanism.XPO1 facilitates the nuclear export of TRIM21, enabling TRIM21-mediated K48-linked ubiquitination and proteasomal degradation of IRF3. This process reduces TNFSF15 expression and contributes to TREM2+ macrophage polarization in SCLC. Targeting the XPO1-TRIM21-IRF3 axis may help limit immunosuppressive macrophage reprogramming and enhance anti-PD-1 immunotherapy efficacy in SCLC. This schematic was created by the authors using Adobe Illustrator and contains no third-party material.
Supplier Page from Abcam for Human TL1A ELISA Kit- Extracellular